J&J’s McNeil Recalls Tylenol Over Complaints of Musty Odor
This article is for subscribers only.
Johnson & Johnson’s consumer unit recalled 750,000 bottles and packages of Tylenol and other over-the-counter drugs that may have been produced on improperly cleaned equipment or tainted by a musty odor.
The McNeil Consumer Healthcare unit is recalling 34,000 bottles of Tylenol 8-hour Extended Release Caplets in the U.S. made before a Fort Washington, Pennsylvania, plant was shut down last April, Bonnie Jacobs, a spokeswoman for New Brunswick, New Jersey-based J&J, said today in an e-mail. McNeil also added 717,696 bottles and packages to a Jan. 14 recall of Tylenol, Benadryl and Sudafed that may have been made on unclean equipment, Jacobs said.